Pragya Kakani on How Protected-Class Policy Impacts Medicare Drug Rebates

Looking to drive meaningful change in the health care ecosystem? Look to the Deloitte Health Equity Institute. Health Affairs' Editor-in-Chief Alan Weil interviews Pragya Kakani of Cornell University about her recent paper exploring the association between Medicare Part D protected-class policy and lower drug rebates. Order the October 2024 issue of Health Affairs. Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.